Anti-Thymocyte Globulin/G-CSF Treatment Preserves Β Cell Function in Patients With Established Type 1 Diabetes
Journal of Clinical Investigation - United States
doi 10.1172/jci78492
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 15, 2014
Authors
Publisher
American Society for Clinical Investigation